COMPANY
Chengdu Brilliant Biopharmaceutical Co., Ltd.
Chengdu Brilliant Biopharmaceutical Co., Ltd.: bulk ingredient labeler, warning letter recipient for Semaglutide, as stated by public registers.
BULK INGREDIENT LABELER
Lists the bulk active ingredient with FDA (NDC directory).
| Semaglutide | Semaglutide, BULK INGREDIENT Regulator openFDA |
|---|
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| Semaglutide | CGMP/Finished Pharmaceuticals/Adulterated, 2025-09-11 Regulator FDA warning letters |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.